| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0011900 | Intron-Exon-Intron | chr10:31661947-31677304 | chr10:31373018-31388375 | 1570 nt | 0.3522 |
| hsa_ZEB1_0011100 | Intron-Exon-Intron | chr10:31661947-31677801 | chr10:31373018-31388872 | 1452 nt | 0.3209 |
| hsa_ZEB1_0012000 | Intron-Exon-Intron | chr10:31661947-31678589 | chr10:31373018-31389660 | 56 nt | 0.4107 |
| hsa_ZEB1_0012200 | Intron-Exon-Intron | chr10:31661947-31680153 | chr10:31373018-31391224 | 224 nt | 0.3929 |
| hsa_ZEB1_0012300 | Intron-Exon-Intron | chr10:31661947-31698662 | chr10:31373018-31409733 | 143 nt | 0.4476 |
| hsa_ZEB1_0011200 | Intron-Exon-Intron | chr10:31661947-31713578 | chr10:31373018-31424649 | 250 nt | 0.2680 |
| hsa_ZEB1_0012500 | Intron-Exon-Intron | chr10:31661947-31714071 | chr10:31373018-31425142 | 109 nt | 0.3394 |
| hsa_ZEB1_0011300 | Intron-Exon-Intron | chr10:31661947-31756382 | chr10:31373018-31467453 | 250 nt | 0.3800 |
| hsa_ZEB1_0011400 | Intron-Exon-Intron | chr10:31661947-31757459 | chr10:31373018-31468530 | 250 nt | 0.3560 |
| hsa_ZEB1_0011500 | Intron-Exon-Intron | chr10:31661947-31768407 | chr10:31373018-31479478 | 250 nt | 0.2960 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].